Ozenoxacin
Ozenoxacin is a non-fluorinated quinolone antimicrobial topical cream. It functions by inhibiting bacterial DNA replication, specifically targeting DNA gyrase and topoisomerase IV, making it highly effective against Gram-positive organisms including drug-resistant strains like MRSA.
Dosage by Body Weight
Apply a thin layer of 1% cream to the affected area twice daily for 5 days. It is for external topical use only; avoid contact with eyes, nose, or mouth.
- Body Weight
- Below 5 kg
- Dose
- Apply a thin layer to affected skin area
- Frequency
- Twice daily for 5 days
- Tracking Notes
- Only use if patient is 2 months of age or older. Safety and efficacy have not been established for infants under 2 months.
- Body Weight
- 5-7 kg
- Dose
- Apply a thin layer to affected skin area
- Frequency
- Twice daily for 5 days
- Tracking Notes
- Suitable for patients aged 2 months and older. The treated area may be covered with a sterile bandage if desired.
- Body Weight
- 8-10 kg
- Dose
- Apply a thin layer to affected skin area
- Frequency
- Twice daily for 5 days
- Tracking Notes
- Suitable for patients aged 2 months and older. Wash hands thoroughly before and after application.
- Body Weight
- 11-15 kg
- Dose
- Apply a thin layer to affected skin area
- Frequency
- Twice daily for 5 days
- Tracking Notes
- Suitable for patients aged 2 months and older. Use only on the skin as prescribed.
- Body Weight
- 16-20 kg
- Dose
- Apply a thin layer to affected skin area
- Frequency
- Twice daily for 5 days
- Tracking Notes
- Suitable for patients aged 2 months and older. Discontinue use and consult a physician if no improvement is seen after 5 days.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Apply a thin layer to affected skin area | Twice daily for 5 days | Only use if patient is 2 months of age or older. Safety and efficacy have not been established for infants under 2 months. |
| 5-7 kg | Apply a thin layer to affected skin area | Twice daily for 5 days | Suitable for patients aged 2 months and older. The treated area may be covered with a sterile bandage if desired. |
| 8-10 kg | Apply a thin layer to affected skin area | Twice daily for 5 days | Suitable for patients aged 2 months and older. Wash hands thoroughly before and after application. |
| 11-15 kg | Apply a thin layer to affected skin area | Twice daily for 5 days | Suitable for patients aged 2 months and older. Use only on the skin as prescribed. |
| 16-20 kg | Apply a thin layer to affected skin area | Twice daily for 5 days | Suitable for patients aged 2 months and older. Discontinue use and consult a physician if no improvement is seen after 5 days. |
Formulation
Purpose
Used for the topical treatment of impetigo caused by Staphylococcus aureus or Streptococcus pyogenes in adults and pediatric patients aged 2 months and older.
Generic Name
OzenoxacinBranded Drug Names
Ozenoxacin is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.